Clinical trials recruiting in Steyr, Austria

Phase breakdown

Conditions recruiting in Steyr, Austria

Recruiting trials in Steyr, Austria

• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
  NCT06065748 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• AGMT Metastatic Colorectal Cancer Registry (mCRC) Third Line and Beyond
  NCT06678919 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Metastatic Breast Cancer in Austria
  NCT03870620 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
  NCT05254171 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Steyr, Austria?

5 recruiting trials have at least one study site in Steyr, Austria.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.